1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Vidal, M.
Gincel, E.
Goudreau, N.
Cornille, F.
Parker, F.
Duchesne, M.
Tocque, B.
Garbay, C.
Roques, B.P.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
290
717
730
10.1006/jmbi.1999.2899
10395825
Molecular and cellular analysis of Grb2 SH3 domain mutants: interaction with Sos and dynamin.
1999
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
1
898
NMR Structure of the N-Terminal SH3 Domain of Grb2 and its Complex with a Proline-Rich Peptide from SOS
1994
10.2210/pdb1aze/pdb
pdb_00001aze
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
6477.309
GRB2
N-TERMINAL SH3 DOMAIN, RESIDUES 1 - 55
Y7V, C32S
1
man
polymer
1173.432
SOS
BINDING SITE IN H-SOS, PEPTIDE VPPPVPPRRR
1
man
polymer
ASH, GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2
no
no
MEAIAKVDFKATADDELSFKRGDILKVLNEESDQNWYKAELNGKDGFIPKNYIEMK
MEAIAKVDFKATADDELSFKRGDILKVLNEESDQNWYKAELNGKDGFIPKNYIEMK
A
polypeptide(L)
no
no
VPPPVPPRRR
VPPPVPPRRR
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
GRB2
9606
FRUIT
Homo sapiens
fruit fly
Drosophila
sample
7227
Drosophila melanogaster
database_2
pdbx_database_status
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
Other
1
0
1999-05-18
1
1
2008-03-24
1
2
2011-07-13
1
3
2021-11-03
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_pdbx_nmr_software.name
_struct_ref_seq_dif.details
Y
BNL
1997-11-17
REL
REL
BEST ENERGY, LEAST RESTRAINT VIOLATION
50
10
NOESY
TOCSY
COSY
NACL 100mM
6.0
1
atm
293
K
SIMULATED ANNEALING ENERGY MINIMIZATION
H2O, PHOSPHATE BUFFER 20MM, NACL 100MM
BIOSYM
refinement
Discover
2.95
structure solution
BRUKER UXNMR + DISCOVER
DISCOVER
600
Bruker
AMX600
MET
1
n
1
MET
1
A
GLU
2
n
2
GLU
2
A
ALA
3
n
3
ALA
3
A
ILE
4
n
4
ILE
4
A
ALA
5
n
5
ALA
5
A
LYS
6
n
6
LYS
6
A
VAL
7
n
7
VAL
7
A
ASP
8
n
8
ASP
8
A
PHE
9
n
9
PHE
9
A
LYS
10
n
10
LYS
10
A
ALA
11
n
11
ALA
11
A
THR
12
n
12
THR
12
A
ALA
13
n
13
ALA
13
A
ASP
14
n
14
ASP
14
A
ASP
15
n
15
ASP
15
A
GLU
16
n
16
GLU
16
A
LEU
17
n
17
LEU
17
A
SER
18
n
18
SER
18
A
PHE
19
n
19
PHE
19
A
LYS
20
n
20
LYS
20
A
ARG
21
n
21
ARG
21
A
GLY
22
n
22
GLY
22
A
ASP
23
n
23
ASP
23
A
ILE
24
n
24
ILE
24
A
LEU
25
n
25
LEU
25
A
LYS
26
n
26
LYS
26
A
VAL
27
n
27
VAL
27
A
LEU
28
n
28
LEU
28
A
ASN
29
n
29
ASN
29
A
GLU
30
n
30
GLU
30
A
GLU
31
n
31
GLU
31
A
SER
32
n
32
SER
32
A
ASP
33
n
33
ASP
33
A
GLN
34
n
34
GLN
34
A
ASN
35
n
35
ASN
35
A
TRP
36
n
36
TRP
36
A
TYR
37
n
37
TYR
37
A
LYS
38
n
38
LYS
38
A
ALA
39
n
39
ALA
39
A
GLU
40
n
40
GLU
40
A
LEU
41
n
41
LEU
41
A
ASN
42
n
42
ASN
42
A
GLY
43
n
43
GLY
43
A
LYS
44
n
44
LYS
44
A
ASP
45
n
45
ASP
45
A
GLY
46
n
46
GLY
46
A
PHE
47
n
47
PHE
47
A
ILE
48
n
48
ILE
48
A
PRO
49
n
49
PRO
49
A
LYS
50
n
50
LYS
50
A
ASN
51
n
51
ASN
51
A
TYR
52
n
52
TYR
52
A
ILE
53
n
53
ILE
53
A
GLU
54
n
54
GLU
54
A
MET
55
n
55
MET
55
A
LYS
56
n
56
LYS
56
A
VAL
1
n
1
VAL
1
B
PRO
2
n
2
PRO
2
B
PRO
3
n
3
PRO
3
B
PRO
4
n
4
PRO
4
B
VAL
5
n
5
VAL
5
B
PRO
6
n
6
PRO
6
B
PRO
7
n
7
PRO
7
B
ARG
8
n
8
ARG
8
B
ARG
9
n
9
ARG
9
B
ARG
10
n
10
ARG
10
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
ALA
3
A
O
ALA
3
A
N
LEU
25
A
N
LEU
25
A
O
LYS
26
A
O
LYS
26
A
N
GLU
40
A
N
GLU
40
A
O
TYR
37
A
O
TYR
37
A
N
ILE
48
A
N
ILE
48
1
A
CB
ILE
48
WRONG HAND
1
A
CB
ILE
53
WRONG HAND
2
A
CB
ILE
4
WRONG HAND
2
A
CB
THR
12
WRONG HAND
2
A
CB
ILE
24
WRONG HAND
2
A
CB
ILE
48
WRONG HAND
2
A
CB
ILE
53
WRONG HAND
3
A
CB
ILE
24
WRONG HAND
3
A
CB
ILE
48
WRONG HAND
3
A
CB
ILE
53
WRONG HAND
4
A
CB
ILE
4
WRONG HAND
4
A
CB
THR
12
WRONG HAND
4
A
CB
ILE
24
WRONG HAND
5
A
CB
THR
12
WRONG HAND
5
A
CB
ILE
24
WRONG HAND
6
A
CB
ILE
24
WRONG HAND
6
A
CB
ILE
53
WRONG HAND
7
A
CB
ILE
24
WRONG HAND
8
A
CB
ILE
4
WRONG HAND
9
A
CB
THR
12
WRONG HAND
9
A
CB
ILE
48
WRONG HAND
10
A
CB
ILE
4
WRONG HAND
1
A
TYR
37
0.102
SIDE CHAIN
3
A
TYR
37
0.101
SIDE CHAIN
4
A
TYR
37
0.097
SIDE CHAIN
1
A
A
C
OXT
LYS
LYS
56
56
0.134
0.019
1.229
1.363
N
2
A
A
C
OXT
LYS
LYS
56
56
0.134
0.019
1.229
1.363
N
3
A
A
C
OXT
LYS
LYS
56
56
0.135
0.019
1.229
1.364
N
4
A
A
C
OXT
LYS
LYS
56
56
0.136
0.019
1.229
1.365
N
5
A
A
C
OXT
LYS
LYS
56
56
0.137
0.019
1.229
1.366
N
6
A
A
C
OXT
LYS
LYS
56
56
0.133
0.019
1.229
1.362
N
7
A
A
C
OXT
LYS
LYS
56
56
0.134
0.019
1.229
1.363
N
8
A
A
C
OXT
LYS
LYS
56
56
0.132
0.019
1.229
1.361
N
9
A
A
C
OXT
LYS
LYS
56
56
0.134
0.019
1.229
1.363
N
10
A
A
C
OXT
LYS
LYS
56
56
0.134
0.019
1.229
1.363
N
1
A
ASP
15
-158.97
-44.52
1
A
SER
32
-168.45
-57.67
1
A
LEU
41
-71.04
-74.25
1
A
ASN
42
-167.59
-59.31
1
B
ARG
9
83.80
130.27
2
A
ASP
15
-156.24
39.27
2
A
ASP
33
-156.13
86.74
2
A
ASN
35
-82.51
49.47
2
B
ARG
9
83.37
158.51
3
A
ALA
13
-170.41
144.09
3
A
ASP
15
-162.12
-61.57
3
A
LYS
20
-97.38
-123.60
3
A
GLU
30
-54.88
-70.27
3
A
SER
32
74.71
118.27
3
A
ASN
42
-13.32
-62.53
3
A
MET
55
-63.36
-80.36
4
A
ASP
15
-170.09
-40.65
4
A
LYS
20
-100.73
-93.81
4
A
ARG
21
-172.70
127.50
4
A
LEU
28
-90.00
-105.81
4
A
ASN
29
-150.36
-75.37
4
A
SER
32
69.71
-65.38
4
A
ASN
35
-170.68
-43.05
4
A
TYR
52
-85.88
39.66
4
A
GLU
54
-69.80
-80.74
4
A
MET
55
52.96
83.55
5
A
THR
12
-88.77
-70.48
5
A
ASP
15
-155.90
-46.64
5
A
LEU
28
-89.79
-76.73
5
A
GLU
31
-123.05
-51.20
5
A
SER
32
-159.31
-82.68
5
A
ASN
42
-159.61
-45.22
5
A
ASN
51
-159.97
-53.75
5
A
MET
55
-66.82
94.62
6
A
ASP
8
-69.92
91.50
6
A
ASP
15
-165.78
-47.73
6
A
LEU
28
-93.68
-68.79
6
A
GLU
30
-173.41
-99.68
6
A
GLU
31
-132.34
-55.08
6
A
SER
32
-161.72
-75.17
6
A
ASP
33
-148.46
50.90
6
A
ASN
42
-176.41
-56.65
6
A
ASN
51
-165.13
-60.00
6
B
ARG
8
-69.31
-72.41
7
A
THR
12
-132.95
-42.28
7
A
GLU
31
-46.92
-73.21
7
A
SER
32
59.61
-158.51
7
A
GLN
34
-137.56
-61.05
7
A
ASN
35
104.02
-12.07
7
A
LEU
41
-108.79
-90.61
7
A
GLU
54
-78.29
-72.91
7
A
MET
55
45.03
74.09
8
A
ASP
15
-160.21
-57.25
8
A
SER
18
82.62
127.05
8
A
GLU
30
-75.86
-121.52
8
A
GLU
31
-79.87
-77.53
8
A
SER
32
60.36
-141.67
8
A
GLN
34
62.57
-178.86
8
A
LEU
41
-139.04
-119.08
9
A
LYS
6
-89.79
46.20
9
A
VAL
7
-147.96
-60.96
9
A
ASP
8
96.02
118.30
9
A
THR
12
-147.04
52.67
9
A
ASP
15
-159.84
-66.05
9
A
LYS
20
-122.96
-131.70
9
A
GLU
31
-67.06
84.98
9
A
ASN
42
-172.06
-50.38
9
A
MET
55
74.50
-56.28
10
A
ASP
8
-66.70
99.31
10
A
GLU
16
-59.28
175.76
10
A
GLU
30
-159.41
-51.05
10
A
GLU
31
66.60
-17.30
10
A
ASP
33
-167.16
-40.71
10
A
LEU
41
-88.15
-81.48
10
A
ASN
42
-172.08
58.35
10
B
ARG
8
-70.80
-77.67
10
B
ARG
9
-164.72
85.27
NMR STRUCTURE OF THE COMPLEX BETWEEN THE C32S-Y7V MUTANT OF THE NSH3 DOMAIN OF GRB2 WITH A PEPTIDE FROM SOS, 10 STRUCTURES
1
N
N
2
N
N
COMPLEX (ADAPTOR PROTEIN/PEPTIDE)
COMPLEX (ADAPTOR PROTEIN-PEPTIDE), SH3 DOMAIN, GUANINE-NUCLEOTIDE RELEASING FACTOR, COMPLEX (ADAPTOR PROTEIN-PEPTIDE) complex
GRB2_HUMAN
UNP
1
1
P62993
SOS_DROME
UNP
2
1342
P26675
1
56
1AZE
1
56
P62993
A
1
1
56
1342
1350
1AZE
1
9
P26675
B
2
1
9
1
TYR
engineered mutation
VAL
7
1AZE
A
P62993
UNP
7
7
1
CYS
engineered mutation
SER
32
1AZE
A
P62993
UNP
32
32
4
anti-parallel
anti-parallel
anti-parallel
A
GLU
2
A
GLU
2
A
ILE
4
A
ILE
4
A
ILE
24
A
ILE
24
A
ASN
29
A
ASN
29
A
TRP
36
A
TRP
36
A
GLU
40
A
GLU
40
A
ASP
45
A
ASP
45
A
PRO
49
A
PRO
49
1
P 1